Optimal individualized treatment regimes for survival data with competing risks

Nikki Freeman Co-Author
Duke University
 
Katharine McGinigle Co-Author
University of North Carolina at Chapel Hill
 
Michael Kosorok Co-Author
University of North Carolina at Chapel Hill
 
Christina Zhou First Author
University of North Carolina at Chapel Hill
 
Christina Zhou Presenting Author
University of North Carolina at Chapel Hill
 
Wednesday, Aug 6: 11:05 AM - 11:20 AM
2760 
Contributed Papers 
Music City Center 
Precision medicine leverages patient heterogeneity to estimate individualized treatment regimes-formalized, data-driven approaches designed to match patients with optimal treatments. In the presence of competing events, where multiple causes of failure can occur and one cause precludes others, it is crucial to assess the risk of a main outcome of interest, such as one type of failure over another. This helps clinicians tailor interventions based on the factors driving that cause, leading to more precise treatment strategies. Currently, no precision medicine methods account for both survival and competing risk endpoints. To address this gap, we develop a nonparametric individualized treatment regime estimator. Our two-phase method accounts for overall survival from all events as well as the cumulative incidence of a main event. Additionally, we introduce a value function that jointly incorporates both outcomes. We develop random forests to construct individual survival and cumulative incidence curves. Simulation studies demonstrated that our proposed method performs well, which we applied to a cohort of peripheral artery disease patients at high risk for limb loss and mortality.

Keywords

precision medicine

random forests

survival analysis

cumulative incidence function 

Main Sponsor

Lifetime Data Science Section